ENTITY

SillaJen Inc (215600 KS)

51

Analysis

Health Care • South Korea

SillaJen, Inc. provides medical research and development services. The Company researches and develops treatment of cancer based on genetic recombination virus. SillaJen conducts its business in South Korea and the United States.

more

Refresh

Exchange Announcement • 27 Nov 2024 16:48

Material Management Information related to Judgment of Investment(Application for Approval for IND Modification)(ì§íì± ê³ íì íìë¥¼ ëìì¼ë¡ BAL0891ì ë¨ì¼ìë² ë° íìííìë²ê³¼ì ë³ì©ìë²ì ëí ìíìì½íìì ì²(MFDS) ì 1ì ìììí ê³í(IND) ë³ê²½ ì¹ì¸ ì ì²)

Exchange Announcement • 15 Nov 2024 16:56

Material Management Information related to Judgment of Investment(Approval for IND Modification)(ì§íì± ê³ íì íìë¥¼ ëìì¼ë¡ BAL0891ì ë¨ì¼ìë² ë° íìííìë²ê³¼ì ë³ì©ìë²ì ëí ë¯¸êµ FDA ì 1ì ìììí ê³í(IND) ë³ê²½ ì¹ì¸)

Exchange Announcement • 16 Oct 2024 15:24

Material Management Information related to Judgment of Investment(Application for Approval for IND Modification)(ì§íì± ê³ íì íìë¥¼ ëìì¼ë¡ BAL0891ì ë¨ì¼ìë² ë° íìííìë²ê³¼ì ë³ì©ìë²ì ëí ë¯¸êµ FDA ì 1ì ìììí ê³í(IND) ë³ê²½ ì¹ì¸ ì ì²)

Exchange Announcement • 08 May 2024 16:59

Ex-Rights(ì ìì¦ì)

Exchange Announcement • 08 May 2024 15:10

Initial (Tentative) Issue Price of Rights Offering

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x